Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

Semaglutide, a drug commonly taken for weight loss, showed marked benefits for most patients in a trial for metabolic ...

A new study published in the New England Journal of Medicine reveals that medications widely used for diabetes and obesity ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by the common condition.

The active ingredient in the popular weight loss drug Wegovy may help treat a type of fatty liver disease, according to a new ...

A new study reveals that semaglutide, a common diabetes medication, may effectively treat fatty liver disease, offering hope ...

Interim results from the Phase III ESSENCE trial published in The New England Journal of Medicine show once-weekly ...

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that the substance ...

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...